Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Raquel Pérez-Robles"'
Autor:
Jesús Hermosilla, Airan Alonso-García, Antonio Salmerón-García, José Cabeza-Barrera, Antonio L. Medina-Castillo, Raquel Pérez-Robles, Natalia Navas
Publikováno v:
Vaccines, Vol 11, Iss 11, p 1635 (2023)
Comirnaty™ and Spikevax™ were the first vaccines approved for human use based on modified non-replicating mRNA lipophilic nanoparticle (mRNA-LNP) technology, with great success in the treatment of COVID-19. They have been used massively worldwide
Externí odkaz:
https://doaj.org/article/8930106c7dd740f692882eb2a4ac8ada
Autor:
Natalia Navas, Jesús Hermosilla, Anabel Torrente-López, José Hernández-Jiménez, Jose Cabeza, Raquel Pérez-Robles, Antonio Salmerón-García
Publikováno v:
Journal of Pharmaceutical Analysis, Vol 10, Iss 6, Pp 532-545 (2020)
COVID-19, a disease caused by the novel coronavirus SARS-CoV-2, has produced a serious emergency for global public health, placing enormous stress on national health systems in many countries. Several studies suggest that cytokine storms (interleukin
Externí odkaz:
https://doaj.org/article/9558f070220e4a558a4a9e25c08f46dc
Autor:
Sara Carillo, Raquel Pérez-Robles, Craig Jakes, Meire Ribeiro da Silva, Silvia Millán Martín, Amy Farrell, Natalia Navas, Jonathan Bones
Publikováno v:
Journal of Pharmaceutical Analysis, Vol 10, Iss 1, Pp 23-34 (2020)
With the size of the biopharmaceutical market exponentially increasing, there is an aligned growth in the importance of data-rich analyses, not only to assess drug product safety but also to assist drug development driven by the deeper understanding
Externí odkaz:
https://doaj.org/article/c07571e6dff449f3bf8a91df0ded9e27
Autor:
Raquel Pérez-Robles, Antonio Salmerón-García, Jesus Hermosilla, Anabel Torrente-López, Susana Clemente-Bautista, Inés Jiménez-Lozano, María Josep Cabañas-Poy, Jose Cabeza, Natalia Navas
Publikováno v:
Scientia
Physico-chemical characterization; Stress testing; Teduglutide Caracterització fisicoquímica; Proves d'estrès; Teduglutida Caracterización físicoquímica; Pruebas de estrés; Teduglutida Teduglutide (Revestive®) is a glucagon-like peptide-2 ana
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::12bc99c7986e8a8e4bafb4272bea8e19
https://hdl.handle.net/11351/9216
https://hdl.handle.net/11351/9216
Autor:
Raquel Pérez-Robles, Antonio Salmerón-García, Susana Clemente-Bautista, Inés Jiménez-Lozano, María Josep Cabañas-Poy, Jose Cabeza, Natalia Navas
Publikováno v:
Scientia
Peptide; Teduglutide; Short bowel syndrome Pèptid; Teduglutida; Síndrome de l'intestí curt Péptido; Teduglutida; Síndrome del intestino corto Teduglutide (Revestive®, 10 mg mL−1) is a recombinant human glucagon-like peptide 2 analogue, used i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::35ece306adb6c29cc4ee6fc9960e86f8
https://hdl.handle.net/10668/19643
https://hdl.handle.net/10668/19643
Autor:
Raquel Pérez-Robles, Jesús Hermosilla, Natalia Navas, Susana Clemente-Bautista, Inés Jiménez-Lozano, Maria Josep Cabañas-Poy, Julio Ruiz-Travé, María Amparo Hernández-García, Jose Cabeza, Antonio Salmerón-García
Publikováno v:
Scientia
Hospital condition; Long-term stability study; Teduglutide Condició hospitalària; Estudi d'estabilitat a llarg termini; Teduglutida Condición hospitalaria; Estudio de estabilidad a largo plazo; Teduglutida Teduglutide, the active ingredient of the
Autor:
Amy Farrell, Meire Ribeiro da Silva, Natalia Navas, Craig Jakes, Silvia Millán Martín, Jonathan Bones, Sara Carillo, Raquel Pérez-Robles
Publikováno v:
Journal of Pharmaceutical Analysis, Vol 10, Iss 1, Pp 23-34 (2020)
Journal of Pharmaceutical Analysis
Journal of Pharmaceutical Analysis
With the size of the biopharmaceutical market exponentially increasing, there is an aligned growth in the importance of data-rich analyses, not only to assess drug product safety but also to assist drug development driven by the deeper understanding
Autor:
Jesús Hermosilla, Salvador Casares, Natalia Navas, Raquel Pérez-Robles, Antonio Salmerón-García, José Cabeza
Publikováno v:
Digibug. Repositorio Institucional de la Universidad de Granada
instname
instname
The study was entirely funded by Project FIS: PI-17/00547(Instituto Carlos III, Ministerio de Economia y Competitividad, Spain), which means that it was also partially supported by European Regional Development Funds (ERDF).
A range of biopharma
A range of biopharma
Autor:
Agustín Herrera, José Cabeza, Antonio Martínez-Ortega, Natalia Navas, Raquel Pérez-Robles, Antonio Salmerón-García
Publikováno v:
SSRN Electronic Journal.
Marketed monoclonal antibodies (mAbs) represent a very important class of the current biopharmaceutics. The great complexity of their structure made necessary the use of different analytical approaches for assessing different physico-chemical propert
Autor:
Antonio Salmerón-García, José Hernández-Jiménez, Natalia Navas, Anabel Torrente-López, Jesús Hermosilla, José Cabeza, Raquel Pérez-Robles
Publikováno v:
Digibug: Repositorio Institucional de la Universidad de Granada
Universidad de Granada (UGR)
Digibug. Repositorio Institucional de la Universidad de Granada
instname
Journal of Pharmaceutical Analysis, Vol 10, Iss 6, Pp 532-545 (2020)
Journal of Pharmaceutical Analysis
Universidad de Granada (UGR)
Digibug. Repositorio Institucional de la Universidad de Granada
instname
Journal of Pharmaceutical Analysis, Vol 10, Iss 6, Pp 532-545 (2020)
Journal of Pharmaceutical Analysis
COVID-19, a disease caused by the novel coronavirus SARS-CoV-2, has produced a serious emergency for global public health, placing enormous stress on national health systems in many countries. Several studies suggest that cytokine storms (interleukin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4b6e38237dd5e7a0655e3dc60a47ea57
https://hdl.handle.net/10668/3505
https://hdl.handle.net/10668/3505